A new study co-authored by our Chief Scientist Dave Tuveson, MD, PhD, Daniel King, MD, PhD, Amber Habowski, PhD and a broader research team explored using AI to flag imaging and connect patients to care faster. More info 👉 lfdn.org/4aJQnjH #ProgressIsParamount

Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial - Nature Communications KRAS mutations are keenly associated with pancreatic ductal adenocarcinoma and represent a potential therapeutic target. Here the authors present the findings from a phase I clinical trial testing poo...

Big step forward in #pancreaticcancer vaccines 💜
Lustgarten’s Chief Medical Advisor, Elizabeth Jaffee, and team published new Nature results on an off-the-shelf KRAS vaccine after surgery:
Read more 👉https://www.nature.com/articles/s41467-026-68324-4
#ResearchIsFundamental #ProgressIsParamount

Clinical trials drive progress in pancreatic cancer—and may offer access to promising new treatments. 💜 As #PancreaticCancerClinicalTrialsAwarenessMonth ends, we encourage patients to talk with their doctor about clinical trial options. 👉 lustgarten.org/clinical-trials #ProgressIsParamount

Mary Osani is celebrating life after pancreatic cancer treatment, including a clinical trial for patients with a BRCA2 mutation. 💜
January is #PancreaticCancerClinicalTrialsAwarenessMonth. Learn more: lfdn.org/clinicaltrials
#ProgressIsParamount @northwellhealth.bsky.social

As we look back on 2025, one thing is clear: we couldn’t have done it without you. 💜 Thank you for being part of the Lustgarten community—our future is brighter because of you. 🫶
#ProgressIsParamount #PancreaticCancer

💜 What if #pancreaticcancer could be found when it’s still curable?
Join us TOMORROW for an exclusive LustgartenLIVE! on the science powering early detection. Register today! 👉Lustgarten.org/ll-unlockearlydetection
#LedByLustgarten #ProgressIsParamount

Once “undruggable,” KRAS—the driver of 90%+ of pancreatic cancers—is finally being challenged. 💜 Our $5M Break Through Cancer partnership is turning discoveries into real impact. Learn more: lfdn.org/state-of-kras
#PCAM #PancreaticCancerAwarenessMonth #ResearchIsFundamental #ProgressIsParamount

💜 What if we could catch pancreatic cancer earlier—when it’s still curable?
Join us for "LustgartenLIVE! Unlocking Early Detection" on November 19.
👉 Don’t miss this powerful conversation: lustgarten.org/ll-unlockearlydetection
#ProgressIsParamount @hopkinsmedicine.bsky.social

What an inspiring week! 💜✨ Our Scientific Advisory Board meeting united top minds in pancreatic cancer research — driving breakthroughs and bringing us closer to a cure. #ResearchIsFundamental #ProgressIsParamount

Arthur Kuan, MS, joins the Lustgarten Foundation Board of Directors Arthur Kuan, MS, joins the Lustgarten Foundation Board of Directors   UNIONDALE, NY, JUNE 30, 2025 – The Lustgarten Foundation, the world’s largest private funder of pancreatic cancer research, today ...

We’re honored to welcome Arthur Kuan, CEO of CG Oncology, to the Lustgarten Foundation Board of Directors. 💜 His biotech and clinical development expertise will help drive bold progress in #pancreaticcancer research. #ProgressIsParamount

👉 lustgarten.org/lustgarten-f...

We’re honored to announce a remarkable $10 million gift from the Paul M. Angell Family Foundation! 💜 This generous investment will fuel our efforts to revolutionize early detection of pancreatic cancer through the power of AI. #ProgressIsParamount
🔗https://lfdn.org/4e7tyGN

Trump administration cut $2.7 billion in NIH research funding through March, Senate committee minority report says | CNN A Senate committee report by minority staff, and obtained by CNN, slams the Trump administration for terminating some funding for research, firing thousands of federal workers and removing certain sci...

A new Senate report reveals $2.7 billion slashed from NIH research funding. At risk? Progress and breakthroughs in cancer research.
👉 Read more: lfdn.org/NIHfunding
#ResearchIsFunamental #ProgressIsParamount

💜 Less is unacceptable-support #pancreaticcancer research today: lustgarten.org/donatenow

FY24 Lustgarten Annual Report

Lustgarten-funded researchers are driving life-saving breakthroughs, bringing hope to patients & families. Together, we're advancing science faster! 💜
📰 Check out our 2024 Annual Report: lustgarten.org/annualreport
#ProgressIsParamount

NCI Cancer Center grants provide support for infrastructure and efficiency that allow the centers to be more productive and allow our dollars to go further in support of research. 💜 Learn more at Lustgarten.org/recent-funding-challenges/
#ResearchIsFundamental #ProgressIsParamount

In addition to the trials mentioned in the article, the Lustgarten Foundation & Break Through Cancer are investigating Daraxonrasib via the joint Conquering KRAS project.
👉 Learn more: lfdn.org/ConqueringKRAS
#ProgressIsParamount

💜In 2021, Lois DeMaio enrolled in a clinical trial that had a tremendous impact on her pancreatic cancer treatment journey. (Read: lfdn.org/3EV74rN)
🔬January is #PancreaticCancerClinicalTrialsAwarenessMonth.
Learn about pancreatic cancer clinical trials here: lfdn.org/40B8lP9
#ProgressIsParamount